Exploring experiences of chronic neuropathic pain- Capsaicin 8% patch

  • Research type

    Research Study

  • Full title

    A qualitative phenomenological study exploring the experiences of adults with chronic neuropathic pain having a Capsaicin 8% patch as a treatment for managing their pain.

  • IRAS ID

    344094

  • Contact name

    Nicola Hickson

  • Contact email

    nicola.hickson@nhs.net

  • Sponsor organisation

    University of Wolverhampton

  • Duration of Study in the UK

    0 years, 7 months, 31 days

  • Research summary

    Chronic neuropathic pain is pain caused by a lesion or disease of the somatosensory nervous system, and the duration of the pain has extended beyond three months. Chronic neuropathic pain is a significant contributor to the worldwide burden of illness and disease, and unfortunately neuropathic pain typically results in suffering and disability when it manifests. The treatment of chronic neuropathic pain is limited, NICE guidelines (2020) recommend initial pharmacological treatment. If these medications are unsuccessful in managing the patient’s pain, a possible second line treatment is a Capsaicin 8% patch.
    Currently the majority of the research that has been performed, focuses on measurements of pain and quality of life when studying chronic neuropathic pain patients having a Capsaicin 8% patch for treating their pain. The research is also mainly quantitative, and it is apparent a gap exists in professionals researching the actual pain experience of this population of patients. The aim of the study is to explore the experiences of patients with chronic neuropathic pain who are being treated for their pain with a Capsaicin 8% patch.

  • REC name

    East of England - Cambridge South Research Ethics Committee

  • REC reference

    24/EE/0165

  • Date of REC Opinion

    28 Aug 2024

  • REC opinion

    Further Information Favourable Opinion